Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antenatal screening for carriers of hepatitis B virus.

× No keyword cloud information.

7 in total

1. Screening for HBsAg in pregnant women: a cost analysis of the universal screening policy in the province of Quebec.

Authors: A M Audet; G Delage; R S Remis
Journal: Can J Public Health Date: 1991 May-Jun

2. Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic.

Authors: J E Banatvala; I L Chrystie; S J Palmer; A Kenney
Journal: Lancet Date: 1990-04-07 Impact factor: 79.321

3. Proposal for routine antenatal screening at 14 weeks for hepatitis B surface antigen. Dutch Study Group on Prevention of Neonatal Hepatitis.

Authors: P M Grosheide; J W Wladimiroff; R A Heijtink; J A Mazel; G C Christiaens; A S Nuijten; S W Schalm
Journal: BMJ Date: 1995-11-04

4. Success of a program of routine prenatal screening for hepatitis B surface antigen: the first 2 years.

Authors: N B Okun; R P Larke; J R Waters; M R Joffres
Journal: CMAJ Date: 1990-12-15 Impact factor: 8.262

5. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.

Authors: V C Wong; H M Ip; H W Reesink; P N Lelie; E E Reerink-Brongers; C Y Yeung; H K Ma
Journal: Lancet Date: 1984-04-28 Impact factor: 79.321

6. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial.

Authors: R P Beasley; L Y Hwang; C E Stevens; C C Lin; F J Hsieh; K Y Wang; T S Sun; W Szmuness
Journal: Hepatology Date: 1983 Mar-Apr Impact factor: 17.425

7. Programme for preventing perinatal hepatitis B infection through screening of pregnant women and immunisation of infants of infected mothers in The Netherlands, 1989-92. National Hepatitis B Steering Committee.

Authors: P M Grosheide; J M Klokman-Houweling; M A Conyn-van Spaendonck
Journal: BMJ Date: 1995-11-04

7 in total

4 in total

Antenatal screening for carriers of hepatitis B virus.

1. Screening for HBsAg in pregnant women: a cost analysis of the universal screening policy in the province of Quebec.

2. Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic.

3. Proposal for routine antenatal screening at 14 weeks for hepatitis B surface antigen. Dutch Study Group on Prevention of Neonatal Hepatitis.

4. Success of a program of routine prenatal screening for hepatitis B surface antigen: the first 2 years.

5. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study.

6. Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial.

7. Programme for preventing perinatal hepatitis B infection through screening of pregnant women and immunisation of infants of infected mothers in The Netherlands, 1989-92. National Hepatitis B Steering Committee.

Review 1. How to assess an article on economic evaluation.

2. Hepatitis B in the Chinese community in Britain.

3. Ante-natal screening for hepatitis B surface antigen: an appraisal of its value in a low prevalence area.

4. Routine antenatal screening for hepatitis B using pooled sera: validation and review of 10 years experience.